T lymphocyte responses against human parvovirus B19: Small virus, big response

Pathologie Biologie

Volumn 50, Issue 5, 2002, Pages 317-325

  Klenerman, Paul ^a   Tolfvenstam, Thomas ^b   Price, David A ^a   Nixon, Douglas F ^c   Broliden, Kristina ^b   Oxenius, Annette ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c GLADSTONE INSTITUTES   (United States)

Author keywords

CD4+ T lymphocyte; CD8+ T lymphocyte; Memory; MHC Class I peptide tetramer; Parvovirus B19

Indexed keywords

CD8 ANTIGEN; HLA ANTIGEN CLASS 1; HLA B35 ANTIGEN;

ARTICLE; CELLULAR IMMUNITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; MEMORY CELL; PARVOVIRUS; SEROLOGY; T LYMPHOCYTE ACTIVATION; VIRUS GENOME; VIRUS INFECTION;

EID: 0036081693     PISSN: 03698114     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0369-8114(02)00306-1     Document Type: Article

References (36)

1. Persistence of B19 parvovirus in pediatric malignancies
2. Prevalence of parvovirus B19 DNA in bone marrow of patients with haematological disorders
3. Clinical and laboratory findings in immunocompetent patients with persistent parvovirus B19 DNA in bone marrow
4. Immunology taught by viruses
5. Immune response to B19 parvovirus and an antibody defect in persistent viral infection
6. On Immunological Memory
7. Immunological memory
8. Immunological memory and protective immunity: Understanding their relation
9. What can we learn about HIV infection from a study of LCMV?
10. Experimental parvoviral infection in humans
11. Disquisitions on original antigenic sin. I evidence in man
12. Cytotoxic T-cell immunity to influenza
13. Direct isolation, phenotyping and cloning of low-frequency antigen-specific cytotoxic T lymphocytes from peripheral blood
14. Analysis of successful immune responses in persons infected with hepatitis C virus
15. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice
16. Viral persistence in vivo through selection of neutralizing antibody-escape variants
17. Persistence of lymphocytic choriomeningitis virus at very low levels in immune mice
18. Human cytomegalovirus-specific cytotoxic T cells: Their precursor frequency and stage specificity
19. Human parvoviruses
20. Direct ex vivo analysis of parovirus B19 specific CD8+ T lymphocytes
21. Lymphoproliferative responses after infection with human parvovirus B19
22. T helper cell-mediated in vitro responses of recently and remotely infected subjects to a candidate recombinant vaccine for human parvovirus B19
23. Impaired gamma interferon responses against parvovirus B19 by recently infected children
24. Use of parvovirus-like particles for vaccination and induction of multiple immune responses
25. Engineering parvovirus-like particles for the induction of B-cell, CD4(+) and CTL responses
26. Recombinant parvovirus-like particles as an antigen carrier: A novel nonreplicative exogenous antigen to elicit protective antiviral cytotoxic T cells
27. Intranasal delivery of recombinant parvovirus-like particles elicits cytotoxic T-cell and neutralizing antibody responses
28. Chronic parvovirus infection in a presumably immunologically healthy woman
29. Persistent B19 parvovirus infection in patients infected with human immunodeficiency virus type 1 (HIV-1): A treatable cause of anemia in AIDS
30. Parvovirus infection in children with AIDS: High prevalence of B19-specific immunoglobulin M and G antibodies
31. Persistence of parvovirus B19 DNA in synovial membranes of young patients with and without chronic arthropathy
32. Integrity and full coding sequence of B19 virus DNA persisting in human synovial tissue
33. Detection of multiple viral DNA species in synovial tissue and fluid of patients with early arthritis
34. Viral arthritis
35. Parvovirus B19 and the pathogenesis of rheumatoid arthritis: A case for historical reasoning
36. Genetic diversity of human parvovirus B19: Sequence analysis of the VP1/VP2 gene from multiple isolates